InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: alabama1man post# 26865

Wednesday, 06/16/2021 1:40:01 PM

Wednesday, June 16, 2021 1:40:01 PM

Post# of 36558
He admits they bent the rules and redirected endpoints to other targets. The US FDA and EU-EMA should be ashamed about their conduct over the last year and a half. So much more could/Should have done.

Successful Clinical Trials should have strong support with the FDA and allowing the expediting of a Re-purposed Drug with a strong safety record.

An relatively inexpensive Pill instead of infusions.?.

The Big Pharma controlled FDA/EMA just changed things for an Alzheimer's drug why not approve COVID/ALI Drug on good Interim data trends with their CT too.?.

The Buc Clinical Trial is using a 28 day following of patients*, so there are a lot of people that have completed their treatments. Is 400 a good point to do an Interim?

The FDA / EMA SHOULD be looking forward with allowing support for treatments, as working with India will be, IMO...GLTA...


* I hope some are followed further as MF implied with mentioning long Haulers.